0 companies available
↑ ↓ to navigate Enter to select Esc to close
JOHNSON & JOHNSON
JNJ
Pharmaceutical Preparations Last filing · Quarter 2 · Jun 28, 2026Export XLSX
| Ratios | LTM | Dec 28, 2025 | Dec 29, 2024 | Dec 31, 2023 | Jan 1, 2023 | Jan 2, 2022 | Jan 3, 2021 | Dec 29, 2019 | Dec 30, 2018 | Dec 31, 2017 | Jan 1, 2017 | Jan 3, 2016 | Dec 28, 2014 | Dec 29, 2013 | Dec 30, 2012 | Jan 1, 2012 | Jan 2, 2011 | Jan 3, 2010 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gross Margin | 67.91% | 67.88% | 69.07% | 68.82% | ||||||||||||||
Operating Margin | 26.81% | 27.17% | 23.92% | 25.84% | ||||||||||||||
Pretax Margin | 25.73% | 34.59% | 18.79% | 17.69% | ||||||||||||||
Effective Tax Rate | 16.51% | 17.73% | 15.71% | 11.53% | ||||||||||||||
Net Margin | 21.48% | 28.46% | 15.84% | 41.28% | ||||||||||||||
Current Ratio | - | 1.03x | 1.11x | 1.16x | ||||||||||||||
Debt to Equity | - | 1.44x | 1.52x | 1.44x | ||||||||||||||
Net Debt to Equity | - | 1.20x | 1.18x | 1.12x | ||||||||||||||
Asset Turnover | - | 47.28% | 49.32% | 50.82% | ||||||||||||||
Return on Equity | - | 32.87% | 19.68% | 51.11% | ||||||||||||||
Return on Assets | - | 13.46% | 7.81% | 20.98% |